113 related articles for article (PubMed ID: 9523687)
1. The urokinase-type-plasminogen-activator receptor (CD87) is a pleiotropic molecule.
Dear AE; Medcalf RL
Eur J Biochem; 1998 Mar; 252(2):185-93. PubMed ID: 9523687
[TBL] [Abstract][Full Text] [Related]
2. Defective cell migration in an ovarian cancer cell line is associated with impaired urokinase-induced tyrosine phosphorylation.
Mirshahi SS; Lounes KC; Lu H; Pujade-Lauraine E; Mishal Z; Bénard J; Bernadou A; Soria C; Soria J
FEBS Lett; 1997 Jul; 411(2-3):322-6. PubMed ID: 9271229
[TBL] [Abstract][Full Text] [Related]
3. Urokinase plasminogen activator receptor (CD87): something old, something new.
Ge Y; Elghetany MT
Lab Hematol; 2003; 9(2):67-71. PubMed ID: 12828301
[TBL] [Abstract][Full Text] [Related]
4. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-type plasminogen activator-induced monocyte adhesion requires a carboxyl-terminal lysine and cAMP-dependent signal transduction.
Li C; Liu JN; Gurewich V
J Biol Chem; 1995 Dec; 270(51):30282-5. PubMed ID: 8530448
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator.
Solberg H; Løber D; Eriksen J; Ploug M; Rønne E; Behrendt N; Danø K; Høyer-Hansen G
Eur J Biochem; 1992 Apr; 205(2):451-8. PubMed ID: 1374026
[TBL] [Abstract][Full Text] [Related]
8. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of endothelial cell movement and tubulogenesis by human recombinant soluble melanotransferrin: involvement of the u-PAR/LRP plasminolytic system.
Michaud-Levesque J; Rolland Y; Demeule M; Bertrand Y; Béliveau R
Biochim Biophys Acta; 2005 Apr; 1743(3):243-53. PubMed ID: 15843038
[TBL] [Abstract][Full Text] [Related]
10. The urokinase receptor and cell migration.
Blasi F
Semin Thromb Hemost; 1996; 22(6):513-6. PubMed ID: 9122717
[TBL] [Abstract][Full Text] [Related]
11. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.
Carmeliet P; Moons L; Dewerchin M; Rosenberg S; Herbert JM; Lupu F; Collen D
J Cell Biol; 1998 Jan; 140(1):233-45. PubMed ID: 9425170
[TBL] [Abstract][Full Text] [Related]
12. Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-u-PAR-PAI-1 system.
Blasi F
Thromb Haemost; 1999 Aug; 82(2):298-304. PubMed ID: 10605717
[No Abstract] [Full Text] [Related]
13. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
[TBL] [Abstract][Full Text] [Related]
14. Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells.
Degryse B; Resnati M; Rabbani SA; Villa A; Fazioli F; Blasi F
Blood; 1999 Jul; 94(2):649-62. PubMed ID: 10397732
[TBL] [Abstract][Full Text] [Related]
15. Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters.
Anichini E; Zamperini A; Chevanne M; Caldini R; Pucci M; Fibbi G; Del Rosso M
Biochemistry; 1997 Mar; 36(11):3076-83. PubMed ID: 9115983
[TBL] [Abstract][Full Text] [Related]
16. Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.
Zheng MH; Fan Y; Panicker A; Smith A; Robertson T; Wysocki S; Robbins P; Papadimitriou JM; Wood DJ
Am J Pathol; 1995 Dec; 147(6):1559-66. PubMed ID: 7495280
[TBL] [Abstract][Full Text] [Related]
17. The urokinase receptor is a major vitronectin-binding protein on endothelial cells.
Kanse SM; Kost C; Wilhelm OG; Andreasen PA; Preissner KT
Exp Cell Res; 1996 May; 224(2):344-53. PubMed ID: 8612711
[TBL] [Abstract][Full Text] [Related]
18. Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells.
Del Rosso M; Anichini E; Pedersen N; Blasi F; Fibbi G; Pucci M; Ruggiero M
Biochem Biophys Res Commun; 1993 Jan; 190(2):347-52. PubMed ID: 8381273
[TBL] [Abstract][Full Text] [Related]
19. Induction of urokinase-type plasminogen activator receptor by IL-1 beta.
Hasegawa T; Sorensen L; Dohi M; Rao NV; Hoidal JR; Marshall BC
Am J Respir Cell Mol Biol; 1997 Jun; 16(6):683-92. PubMed ID: 9191470
[TBL] [Abstract][Full Text] [Related]
20. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
